DAX®15.234,16+0,21%TecDAX®3.483,12+0,22%Dow Jones 3033.800,60+0,89%Nasdaq 10013.845,05+0,63%
finanztreff.de

DGAP-PVR: Epigenomics AG: Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution

| Quelle: Dow Jones Newsw... | Lesedauer etwa 4 min. | Text vorlesen Stop Pause Fortsetzen

DGAP Voting Rights Announcement: Epigenomics AG
Epigenomics AG: Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the
objective of Europe-wide distribution
2021-02-25 / 09:40
Dissemination of a Voting Rights Announcement transmitted by DGAP - a service of EQS Group AG.
The issuer is solely responsible for the content of this announcement.
Notification of Major Holdings
1. Details of issuer


Name: Epigenomics AG

Street: Geneststraße 5

Postal code: 10829

City: Berlin
Germany

Legal Entity Identifier (LEI): 549300X1C4U862NDLN97
2. Reason for notification


X Acquisition/disposal of shares with voting rights

Acquisition/disposal of instruments

Change of breakdown of voting rights

Other reason:
3. Details of person subject to the notification obligation


Legal entity: Morgan Stanley
City of registered office, country: Wilmington, Delaware, United States of America (USA)
4. Names of shareholder(s) holding directly 3% or more voting rights, if different from 3.


Morgan Stanley & Co. LLC
5. Date on which threshold was crossed or reached:


18 Feb 2021
6. Total positions


% of voting rights % of voting rights through Total of
attached to shares instruments both in % Total number of voting rights
(total of 7.a.) (total of 7.b.1 + 7.b.2) (7.a. + pursuant to Sec. 41 WpHG
7.b.)

New 9.95 % 0.002546157594 % 9.95 % 5891230

Previous 10.26 % 0.00 % 10.26 % /
notification
7. Details on total positions a. Voting rights attached to shares (Sec. 33, 34 WpHG)


ISIN Absolute In %

Direct Indirect Direct Indirect
(Sec. 33 WpHG) (Sec. 34 WpHG) (Sec. 33 WpHG) (Sec. 34 WpHG)

DE000A3H2184 0 586117 0.00 % 9.95 %

Total 586117 9.95 %
b.1. Instruments according to Sec. 38 (1) no. 1 WpHG


Type of instrument Expiration or maturity date Exercise or conversion Voting rights absolute Voting rights in %
period

0 0.00 %

Total 0 0.00 %
b.2. Instruments according to Sec. 38 (1) no. 2 WpHG


Type of Expiration or maturity Exercise or conversion Cash or physical Voting rights Voting rights
instrument date period settlement absolute in %

Convertible 29.02.2024 at any time Physical 150 0 %
Bond

Total 150 0.002546157594
%
8. Information in relation to the person subject to the notification obligation


Person subject to the notification obligation is not controlled nor does it control any other
undertaking(s) that directly or indirectly hold(s) an interest in the (underlying) issuer (1.).

X Full chain of controlled undertakings starting with the ultimate controlling natural person or legal
entity:



Name % of voting rights (if at % of voting rights through instruments Total of both (if at
least 3% or more) (if at least 5% or more) least 5% or more)

Morgan Stanley % % %

Morgan Stanley Capital % % %
Management, LLC

Morgan Stanley Domestic % % %
Holdings, Inc.

Morgan Stanley & Co. LLC 9.66 % % 9.66 %

- % % %

Morgan Stanley % % %

Morgan Stanley
International Holdings % % %
Inc.

Morgan Stanley % % %
International Limited

Morgan Stanley Investments % % %
(UK)

Morgan Stanley & Co. % % %
International plc

- % % %

Morgan Stanley % % %

Morgan Stanley Capital % % %
Management, LLC

Morgan Stanley Domestic % % %
Holdings, Inc.

E*TRADE Financial % % %
Holdings, LLC

ETCM Holdings, LLC % % %

E*TRADE Securities LLC % % %
9. In case of proxy voting according to Sec. 34 para. 3 WpHG (only in case of attribution of voting rights in accordance with Sec. 34 para. 1 sent. 1 No. 6 WpHG) Date of general meeting: Holding total positions after general meeting (6.) after annual general meeting:


Proportion of voting rights Proportion of instruments Total of both

% % %
10. Other explanatory remarks:


The notification was triggered due to a disposal of client securities over which E*TRADE Securities LLC had a right
of use.
Date


24 Feb 2021


2021-02-25 The DGAP Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases. Archive at www.dgap.de


Language: English
Company: Epigenomics AG
Geneststraße 5
10829 Berlin
Germany
Internet: www.epigenomics.com

End of News DGAP News Service

1171034 2021-02-25

END) Dow Jones Newswires

February 25, 2021 03:40 ET ( 08:40 GMT)
Werbung

Das könnte Sie auch interessieren

News-Suche

Suchbegriff:

Aktuelle Videos

HSBC Trading TV

Werbung

Trading-Tipp

Börsen & Märkte

US-Marktüberblick

zur Mediathek
Werbung

Werbung
Diese Seite empfehlenschliessen
Interessant, oder?
Teilen Sie diese Seite auf Facebook oder Twitter
Wenn Sie auf die Teilen-Buttons klicken und sich bei den Betreibern einloggen, werden Daten an den jeweiligen Betreiber übermittelt. Bitte beachten Sie die Datenschutzerklärung.
Aktuelle Umfrageschliessen
Wie, glauben Sie, wird der DAX am Ende dieser Woche - KW 15 - stehen?
Jetzt abstimmen!
Alle Umfragen ansehen